External validity of randomized controlled trials in COPD.
about
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary diseaseThe external validity of published randomized controlled trials in primary care.Proportional classifications of COPD phenotypes.Systemic Inflammation in Older Adults With Asthma-COPD Overlap SyndromeDistinguishing adult-onset asthma from COPD: a review and a new approach.Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary diseasePrimary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation studyChronic obstructive pulmonary disease self-management activation research trial (COPD-SMART): results of recruitment and baseline patient characteristicsThe Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methodsThe rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010.Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturationSafety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.Making trials matter: pragmatic and explanatory trials and the problem of applicability.Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.How to assess the external validity of therapeutic trials: a conceptual approach.Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.The asthma COPD overlap syndrome (ACOS).Health Status of Patients With Chronic Obstructive Pulmonary Disease by Symptom LevelUse of inhaled corticosteroids in COPD: improving efficacy.Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap.Practical trials in medical education: linking theory, practice and decision making.The Reemergence of the Asthma-COPD Overlap Syndrome: Characterizing a Syndrome in the Precision Medicine Era.Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.A cohort study following up on a randomised controlled trial of a telemedicine application in COPD patients.An Official American Thoracic Society Workshop Report. A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders.How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry.Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.Lessons from Mackenzie that still resonate.Complementing the randomized controlled trial evidence base. Evolution not revolution.Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis.Real-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort study.Asthma prescribing: Where are we headed?Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study.A hypothesis to phenotype COPD exacerbations by aetiology.Commentary: a thesis that still warrants defence and promotion.Clinical phenotypes of obstructive airway diseases in an outpatient population.
P2860
Q26823339-AE4AF33E-53EC-495E-8D01-B8A6122D2BE6Q33400855-3A7844F3-ABE5-40FD-8417-BDBBD9F08C3DQ33824058-EBFCF612-6AEF-418A-ADB7-63F78E4C7237Q33831583-32C4E761-490C-49F2-BF10-90E63FA40C3FQ34198033-403C3AEA-3A6B-41BC-9E03-8E9812CD5650Q34986952-DB184D8B-6D53-4883-871C-D71E66C5667EQ35112110-EBF71F99-467C-48AF-95F1-A4DFB40DF8F6Q35236502-DE9ED199-A590-46D9-AA44-E2ED6BE2FFAFQ35541219-62C5B3C7-8CE3-4155-A928-F89FA42224F7Q35562646-1BA7E024-5944-4918-9387-145389DA5B9FQ35574530-229B6F3F-9960-4642-BA05-42731883853CQ36251424-51EF9810-E1FF-4C57-8692-236B95AB1098Q37236900-7B51EF5C-636A-4570-A64A-52ED14851A0CQ37278903-C0BFFB75-961A-4D0C-A0CE-9D89DF365F17Q37450517-4E2FABE9-0423-4F1B-9654-26F891212810Q37468663-E692F4D4-E36F-4674-8D73-D38524934A0AQ37732345-A060C4CA-4F8F-45AA-ABC2-D87CA82856BCQ38052932-B6504FA9-BF69-4EBE-A834-52EA0BCBA847Q38066413-9A852851-C6E0-41FF-BF2C-BCC384E08170Q38364870-F89BB666-B143-4FEA-BCC8-75FB9B5CD493Q38604633-00546F0F-6EC1-43F5-92A1-AF4173749B61Q38726082-71A44948-6E1F-49A1-943F-8188BD8F6355Q38782541-7FDFE212-4775-47DC-A58E-9A18F6D13033Q38800513-C0AABD2D-1F44-4040-89F0-72F43694245EQ38802244-37937384-CBB0-4787-B6C6-617562C63924Q38994562-4494AECD-2AC9-4EDF-A522-3F68ABCC3FFEQ39030342-3D3BAA6D-5F0A-4002-91F1-7E39D3399FF3Q40861408-033A3574-804D-46D9-BB32-588C49682706Q41028046-37E9C285-1FE9-4A1B-8D3B-8742D13F45EEQ42333511-D5E7C900-C3E0-472B-AB02-B687F8B44A69Q43239278-1415497B-4413-4B62-8519-B98304F471DBQ45829435-70B38D18-5193-4DDA-B9A2-7DB79DA303ACQ45908018-786BCAA1-80A3-4E91-A8CB-646EC00D69EAQ47177016-3E24A29D-8028-4089-A792-4B22B67388AAQ47648921-1AC73FC6-07EC-4B3D-AC89-5B16BE2B39FBQ47723917-2A4FF46E-C349-47B1-B1DD-C975F74EDC20Q48014456-253FB534-59AF-4ADC-8E18-7C0F1ADA1E42Q48319667-33BFBF40-E47D-43C5-8997-7C819B24C0B9Q48324730-3544A812-5166-4C8E-B38C-CD9232F052EBQ53790253-6BB3E82C-3585-4D5C-9FB4-F8AAEA1F803E
P2860
External validity of randomized controlled trials in COPD.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
External validity of randomized controlled trials in COPD.
@en
External validity of randomized controlled trials in COPD.
@nl
type
label
External validity of randomized controlled trials in COPD.
@en
External validity of randomized controlled trials in COPD.
@nl
prefLabel
External validity of randomized controlled trials in COPD.
@en
External validity of randomized controlled trials in COPD.
@nl
P2093
P50
P1433
P1476
External validity of randomized controlled trials in COPD.
@en
P2093
Mark Weatherall
Mathew Williams
Philippa Shirtcliffe
Sarah Aldington
Suzanne Marsh
P304
P356
10.1016/J.RMED.2006.10.011
P577
2006-11-17T00:00:00Z